10:55 AM
Aug 29, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Inflammation

Cell culture, mouse, rat and dog studies identified a RORγT inverse agonist that could help treat inflammation. Chemical synthesis and screening of a subset of Pfizer Inc.’s small compound library in a HEK-cell based activity assay, followed by optimization and testing of the top hit in a human T...

Read the full 227 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >